文献速递中药与中成药合理使用中医内科

基于深度学习与拓扑结构的多靶点抗癌植物化学物归经分类

Multi-target meridians classification based on the topological structure of anti-cancer phytochemicals using deep learning.
PubMed 文献 · J Ethnopharmacol · 2023-09-28

本研究从CancerHSP、ETCM和Hit 2.0数据库收集354种抗癌中药、对应归经及5471种成分化合物,构建GRMC深度学习混合模型(图卷积网络与循环神经网络)基于分子图预测多靶点归经。模型在测试集上平均准确率0.855、平均精确率0.891,优于其他先进算法及传统固定指纹方法,为中药归经提供分子层面科学依据。

要点

  • 抗癌中药与肺、肝、胃、脾经关系密切,不同归经中药治疗特定癌症属性不同。
  • GRMC模型基于分子图拓扑结构预测多靶点归经,测试集平均准确率0.855、平均F1值0.849。
  • 化合物具有多靶点归经的高阶相关性特征,模型可捕捉这种复杂对应关系。

核心结论

  • GRMC模型可通过中药化合物的神经图特征预测多靶点归经,性能优于多种对比方法。
  • 该方法可为理解中医归经的分子科学证据提供基础。

研究设计与样本

  • 从CancerHSP、ETCM和Hit 2.0公共数据库收集354种抗癌中药、对应中医归经及5471种成分化合物。
  • 进行中药与化合物数据集统计分析、关联癌症聚类分析及归经相关性分析。
  • 采用图卷积网络(GCN)与循环神经网络(RNN)组成的GRMC深度学习混合模型,基于分子图生成归经多标签序列。

主要发现

  • 抗癌中药与肺、肝、胃、脾经关系紧密,不同归经中药治疗特定癌症表现不同属性。
  • 某些癌症类型存在共现,如卵巢癌、膀胱癌和宫颈癌。
  • 化合物具有多靶点归经的高阶相关特征。
  • GRMC在测试集上单错误率0.183、汉明损失0.112、平均准确率(MAA)0.855、平均精确率(MAP)0.891、平均召回率(MAR)0.812、平均F1值(MAF)0.849。
  • GRMC在数据集上整体性能优于其他先进算法及处理常规固定指纹的先前方法。

关键数值与推荐

  • GRMC测试集单错误率0.183、汉明损失0.112。
  • GRMC测试集平均准确率(MAA)0.855、平均精确率(MAP)0.891。
  • GRMC测试集平均召回率(MAR)0.812、平均F1值(MAF)0.849。

临床怎么用

  • 可辅助理解抗癌中药归经的分子层面特征,为临床处方提供归经相关参考。
  • 模型预测的多靶点归经信息可用于中药化合物潜在作用经络的探索。

局限性

  • 原文未明确报告模型在外部队列或实验验证中的表现。
  • 原文未明确报告模型对未见中药或化合物的泛化能力评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Traditional Chinese medicine (TCM) meridian is the key theoretical guidance of prescription against tumor in clinical practice. However, there is no scientific and systematic verification of therapeutic action of herbs under meridians context. Several studies have determined the Chinese herbal medicine (CHM) phytochemicals for intrinsic attribute or meridians classification based on artificial intelligence (AI) tools. However, it is challenging to represent the complex molecular structures with large heterogeneity through the current technologies. In addition, the multiple correspondence between herbs and meridians has not been paid much attention. AIM OF THE STUDY: We aim to develop an AI framework to classify multi-target meridians through the topological structure of phytochemicals. MATERIALS AND METHODS: A total of 354 anti-cancer herbs, their corresponding TCM meridians and 5471 ingredient compounds were collected from public databases of CancerHSP, ETCM, and Hit 2.0. The statistical analysis of herbal and compound datasets, clustering analysis of the associated cancers, and correlational analysis of meridian tropism were preliminary conducted. Then a deep learning (DL) hybrid model named GRMC consisting of graph convolutional network (GCN) and recurrent neural network (RNN) was employed to generate the meridian multi-label sequences based on molecular graph. RESULTS: The curing herbs against tumors have tight relationships to lung, liver, stomach, and spleen meridians. These herbs behave different properties in curing certain cancer. Certain cancer types have co-occurrence such as ovarian, bladder and cervical cancer. Compounds have multitarget meridians with characteristics of higher-order correlations. Compared with the other state-of-the-art algorithms on the datasets and previous methods dealing with conventional fixed fingerprints of herbal compounds, the proposed GRMC has superior overall performance on testing dataset with the one error of 0.183, hamming loss of 0.112, mean averaged accuracy (MAA) of 0.855, mean averaged precision (MAP) of 0.891, mean averaged recall (MAR) of 0.812, and mean averaged F1 score (MAF) of 0.849. CONCLUSIONS: The proposed method can predict multi-targeted meridians through neural graph features in herbal compounds and outperforms several comparison methods. It could provide a basis for understanding the molecular scientific evidence of TCM meridians.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang S, Zhang X, Du J, et al. Multi-target meridians classification based on the topological structure of anti-cancer phytochemicals using deep learning. J Ethnopharmacol. 2023. PMID: 37777031. doi:10.1016/j.jep.2023.117244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。